IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.697
+0.019 (2.74%)
At close: Dec 5, 2025, 4:00 PM EST
0.714
+0.017 (2.45%)
After-hours: Dec 5, 2025, 7:59 PM EST
IO Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 30.66 | 60.03 | 143.19 | 142.59 | 211.53 | 3.41 | Upgrade
|
| Cash & Short-Term Investments | 30.66 | 60.03 | 143.19 | 142.59 | 211.53 | 3.41 | Upgrade
|
| Cash Growth | -61.76% | -58.08% | 0.42% | -32.59% | 6112.36% | -56.60% | Upgrade
|
| Other Receivables | 0.99 | 1.13 | 1.13 | 1.53 | 2.09 | 1.5 | Upgrade
|
| Receivables | 0.99 | 1.13 | 1.13 | 1.53 | 2.09 | 1.5 | Upgrade
|
| Prepaid Expenses | 0.29 | 1.12 | 1.35 | 1.72 | 3.2 | - | Upgrade
|
| Other Current Assets | 4.89 | 2.67 | 1.58 | 2.38 | 4.92 | 0.73 | Upgrade
|
| Total Current Assets | 36.83 | 64.95 | 147.26 | 148.22 | 221.74 | 5.64 | Upgrade
|
| Property, Plant & Equipment | 1.85 | 2.36 | 3.11 | 3.23 | 0.16 | - | Upgrade
|
| Other Long-Term Assets | 1.28 | 0.39 | 0.36 | 0.35 | 0.4 | 0.02 | Upgrade
|
| Total Assets | 39.96 | 67.7 | 150.72 | 151.81 | 222.29 | 5.65 | Upgrade
|
| Accounts Payable | 5.59 | 4.66 | 3.88 | 4 | 3.93 | 0.52 | Upgrade
|
| Accrued Expenses | 11.45 | 13.61 | 10.62 | 4.21 | 5.92 | 2.27 | Upgrade
|
| Current Portion of Leases | 0.79 | 0.72 | 0.66 | 0.52 | - | - | Upgrade
|
| Other Current Liabilities | 0.49 | 0.5 | 0.56 | 1.95 | 0.46 | 0.26 | Upgrade
|
| Total Current Liabilities | 18.31 | 19.49 | 15.72 | 10.68 | 10.31 | 3.05 | Upgrade
|
| Long-Term Leases | 0.67 | 1.2 | 1.84 | 2.28 | - | - | Upgrade
|
| Other Long-Term Liabilities | 3.4 | - | - | - | 0.06 | - | Upgrade
|
| Total Liabilities | 39.05 | 20.68 | 17.56 | 12.95 | 10.36 | 3.05 | Upgrade
|
| Common Stock | 0.07 | 0.07 | 0.07 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 424.34 | 413.11 | 406.59 | 326.71 | 319.67 | 1.11 | Upgrade
|
| Retained Earnings | -416.33 | -359.31 | -263.82 | -177.74 | -106.28 | -38.4 | Upgrade
|
| Comprehensive Income & Other | -7.17 | -6.85 | -9.67 | -10.14 | -1.49 | 1.96 | Upgrade
|
| Total Common Equity | 0.91 | 47.02 | 133.16 | 138.85 | 211.92 | -35.3 | Upgrade
|
| Shareholders' Equity | 0.91 | 47.02 | 133.16 | 138.85 | 211.92 | 2.6 | Upgrade
|
| Total Liabilities & Equity | 39.96 | 67.7 | 150.72 | 151.81 | 222.29 | 5.65 | Upgrade
|
| Total Debt | 18.12 | 1.92 | 2.49 | 2.79 | - | - | Upgrade
|
| Net Cash (Debt) | 12.55 | 58.12 | 140.7 | 139.8 | 211.53 | 3.41 | Upgrade
|
| Net Cash Growth | -83.95% | -58.70% | 0.64% | -33.91% | 6112.36% | - | Upgrade
|
| Net Cash Per Share | 0.19 | 0.88 | 3.23 | 4.85 | 48.79 | 19.22 | Upgrade
|
| Filing Date Shares Outstanding | 71.95 | 65.88 | 65.88 | 28.82 | 28.82 | 0.18 | Upgrade
|
| Total Common Shares Outstanding | 69.69 | 65.88 | 65.88 | 28.82 | 28.82 | 0.18 | Upgrade
|
| Working Capital | 18.52 | 45.47 | 131.54 | 137.54 | 211.43 | 2.59 | Upgrade
|
| Book Value Per Share | 0.01 | 0.71 | 2.02 | 4.82 | 7.35 | -199.23 | Upgrade
|
| Tangible Book Value | 0.91 | 47.02 | 133.16 | 138.85 | 211.92 | -35.3 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | 0.71 | 2.02 | 4.82 | 7.35 | -199.23 | Upgrade
|
| Machinery | 1.32 | 1.22 | 1.18 | 0.86 | 0.17 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.